3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
125
Terminated
42
Active not recruiting
22
Recruiting
13
Withdrawn
11
Unknown
7
Not yet recruiting
4
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
toripalimab
1
tislelizumab
1
pembrolizumab
1
ibrutinib
1
fludarabine
1
dynorphin-converting endopeptidase
1
Spinal Puncture
1
Propranolol
1
Positron-Emission Tomography
1
Nivolumab
1
Magnetic Resonance Imaging
1
JNJ-64619178
1
JNJ-64264681
1
Gemcitabine
1
Dexamethasone
1
Deoxycholic Acid
1
Cyclophosphamide
1
Cisplatin
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Enrolling by invitation
×
Dexamethasone
×
Clear all
NCT07014462
2025-10-06
DLIT-AML
University of Vermont
Phase 1
Enrolling by invitation
20 enrolled